Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

Hisse Senetlerindeki Sıralama #3276
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
Hisse Fiyatı
$31.84
Piyasa Değeri
$5.25B
Değişim (1 gün)
-4.46%
Değişim (1 yıl)
45.77%
Ülke
IN
Ticaret Gland Pharma Limited (GLAND)

Kategori

Healthcare
Gland Pharma Limited (GLAND) için temettü verimi geçmişi
Gland Pharma Limited (hisse sembolü: GLAND) temettü verimi (TTM) 2024-03-31 itibariyle: 0.00%
Son 5 yılın ortalama temettü verimi: 0.26%
Gland Pharma Limited (GLAND) için 2017 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
2026 (TTM) 0.66% -48.84%
2025 1.29% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
Benzer şirketler veya rakiplerin temettü verimi (TTM)